Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 27 - Drugs for disorders of the senses
Patents for A61P 27 - Drugs for disorders of the senses (53,017)
08/2012
08/23/2012WO2012110665A1 Aqueous ionic solution containing seawater and at least one compound that is originally immiscible with seawater
08/23/2012WO2012110017A1 Dietetic or pharmaceutical preparation containing tartary buckwheat
08/23/2012WO2012091278A3 Nanoemulsion-type ophthalmic composition
08/23/2012WO2012080497A3 Use of lp-pla2 inhibitors in the treatment and prevention of eye diseases
08/23/2012WO2012074237A3 Liquid medicine composition including dorzolamide and brimonidine for ophthalmology
08/23/2012US20120214869 Novel ligand activators of the rar receptors and pharmaceutical/cosmetic applications thereof
08/23/2012US20120214858 Imidamide sphingosine kinase inhibitors
08/23/2012US20120214852 Alkoxy Compounds for Disease Treatment
08/23/2012US20120214842 Methods for treating diseases of the retina
08/23/2012US20120214841 Solid forms of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide
08/23/2012US20120214838 THERAPEUTICALLY USEFUL SUBSTITUTED HYDROPYRIDO [3,2,1-ij] QUINOLINE COMPOUNDS
08/23/2012US20120214837 Substituted 6,7-dialkoxy-3-isoquinolinol derivatives as inhibitors of phosphodiesterase 10 (pde10a)
08/23/2012US20120214792 Thieno- adn furo-pyrimidine modulators of the histamine h4 receptor
08/23/2012US20120214729 Composition for preventing or treating inflammation
08/23/2012US20120213863 Therapeutic gas for the treatment of mitochondrial disorders
08/23/2012US20120213841 Ophthalmic drug delivery system and method
08/23/2012US20120213840 Ocular strips
08/23/2012US20120213831 Microspheres for active embolization
08/23/2012US20120213823 Compositions comprising polyunsaturated fatty acid monoglycerides, derivatives thereof and uses thereof
08/23/2012US20120213807 Neprilysin inhibitors
08/23/2012US20120213806 Neprilysin inhibitors
08/23/2012US20120213777 Vascular endothelial growth factor 2
08/23/2012US20120213767 Extended Soluble PH20 Polypeptides and uses thereof
08/23/2012US20120213731 Methods and compositions for treating autoimmune diseases
08/23/2012US20120213727 Therapeutic uses of oligomeric and polymeric monoterpenes
08/23/2012US20120213717 Soothing Agents
08/23/2012CA2827563A1 Aqueous ionic solution containing seawater and at least one compound that is originally immiscible with seawater
08/23/2012CA2827509A1 Methods for treating diseases of the retina
08/22/2012EP2489663A1 Compounds as syk kinase inhibitors
08/22/2012EP2488530A1 Spirocyclic piperidine derivatives useful as renin inhibitors
08/22/2012EP2488513A2 2,6-diaminopyridine compounds suitable for treating diseases associated with amyloid or amyloid-like proteins or for treating or preventing ocular diseases or conditions associated with a pathological abnormality/change in the tissue of the visual system
08/22/2012EP1503777B1 7-Hydroxy chromones as potent antioxidants
08/22/2012EP1200431B3 Quinuclidine derivatives and their use as muscarinic m3 receptors ligands
08/22/2012CN1997741B Novel mite allergen
08/22/2012CN1767839B Antiallergic composition
08/22/2012CN1449825B Method for inactivating Bordetella bronchiseptica culture, bacteria composition prepared by same and vaccine having same and use thereof
08/22/2012CN102648005A Carrier
08/22/2012CN102643818A Oligoribonucleotides and methods of use thereof for treatment of alopecia, acute renal failure and other diseases
08/22/2012CN102641443A Chinese medicament for treating dizziness
08/22/2012CN102641431A Medicament for treating vitreous opacity
08/22/2012CN102641387A Method for supercritically extracting natural activity ingredient oil tea polyphenol from oil tea fruits
08/22/2012CN102641316A Method for extracting bioactive substances from marigold slag through subcritical water extraction technology
08/22/2012CN102641242A Method for preparing composite phospholipid sterol lipid
08/22/2012CN102266329B Pharmaceutical composition comprising vinpocetine compound and preparation method thereof
08/22/2012CN102198232B Method for preparing Chinese medicine for treating suppurative otitis media
08/22/2012CN102188683B Preparation method of traditional Chinese medicine for treating otitis media with nasal swelling
08/22/2012CN102119821B Health-protecting material, application thereof in preparing health-protecting pillow and cushion, and health-protecting pillow and cushion
08/22/2012CN101948439B Extraction method and application to medicine of active alkaloid compounds in cervus nippon temminck
08/22/2012CN101890071B Method for identifying Gentiana rigescens Franch and Gentiana manshurica Kitag medicinal materials
08/22/2012CN101346346B Amine compound and use thereof for medical purposes
08/21/2012CA2495830C The use of the combination of ciclesonide and antihistamines for the treatment of allergic rhinitis
08/21/2012CA2472920C Methods of reducing angiogenesis
08/21/2012CA2469490C Method of preparing delta-9 tetrahydrocannabinol
08/21/2012CA2469076C Pharmaceutical compositions comprising dihydropyridinone compounds and an immunoregulatory or an antiinflammatory agent and their uses
08/21/2012CA2371723C Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes, hyperlipidemia and hyperuricemia
08/16/2012WO2012109673A1 Methods of treating macular edema using antiedema therapeutics
08/16/2012WO2012109544A1 Novel 1-(1-oxo-1,2,3,4-tetrahydroisoquinolin-7-yl)urea derivatives as n-formyl peptide receptor like-1 (fprl-1) receptor modulators
08/16/2012WO2012109464A2 Modified peptide that reduces pain in peripheral neuropathy
08/16/2012WO2012108841A1 Transglutaminase-2 inhibitors and uses thereof
08/16/2012WO2012108489A1 Aqueous composition having improved hydrophilic drug penetrability
08/16/2012WO2012108478A1 Monocyclic compound
08/16/2012WO2012107769A1 Treatment of allergic disorders
08/16/2012WO2012107073A1 Ubiad1 for cellular coenzyme q10 synthesis and cardiovascular oxidative protection
08/16/2012WO2012085165A4 Tear substitutes
08/16/2012WO2011105099A8 Compound containing a novel 4-alkoxypyrimidine formation and medicine containing same
08/16/2012US20120209050 Novel pyridopyrazine derivatives, process of manufacturing and uses thereof
08/16/2012US20120208848 Gacyclidine formulations
08/16/2012US20120208842 Novel 1-(1-OXO-1,2,3,4-TETRAHYDROISOQUINOLIN-7-YL)Urea Derivatives As N-FORMYL Peptide Receptor Like-1 (FPRL-1) Receptor Modulators
08/16/2012US20120208840 Condensed Ring Pyridine Compounds As Subtype-Selective Modulators Of Sphingosine-1-Phosphate-2 (S1P2) Receptors
08/16/2012US20120208831 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions
08/16/2012US20120208821 Alpha adrenergic receptor modulators
08/16/2012US20120208805 Triazolium salts as par1 inhibitors, production thereof, and use as medicaments
08/16/2012US20120208793 Thieno- and furo-pyrimidine modulators of the histamine h4 receptor
08/16/2012US20120208766 Topical corneal analgesia using neurotensin receptor agonists and synergistic neurotensin combinations without delaying wound healing
08/16/2012US20120208763 Nap alpha-aminoisobutyric acid analog with neuroprotective activity
08/16/2012US20120208752 Cell proliferation-promoting peptide and use thereof
08/16/2012US20120207849 Amniotic Membrane Preparations and Purified Compositions and Anti-Angiogenesis Treatment
08/16/2012US20120207810 Kinase Inhibitors
08/16/2012US20120207809 Method and system for effecting changes in pigmented tissue
08/16/2012US20120207796 Polymeric drug delivery compositions and methods for treating ophthalmic diseases
08/16/2012US20120207789 Topical corneal analgesia using neurotensin receptor agonists and synergistic neurotensin combinations without delaying wound healing
08/16/2012US20120207752 Methods for modulating il-33 activity
08/16/2012US20120207743 Inhibiting Aberrant Blood Vessel Formation Using Retargeted Endopeptidases
08/16/2012US20120207734 Methods of Inhibiting Aberrant Blood Vessel Formation Using Opioid Retargeted Endpeptidases
08/16/2012US20120207713 Probiotic bifidobacterium strains
08/16/2012US20120207704 Inhibiting Aberrant Blood Vessel Formation Using Growth Factor Retargeted Endopeptidases
08/16/2012US20120207701 Bi-modal hyaluronate
08/16/2012US20120207682 Methods of treating macular edema using antiedema therapeutics
08/16/2012US20120207681 Chemical compositions to detect and treat amyloid in a patients brain and retina
08/16/2012CA2827082A1 Methods of treating macular edema using antiedema therapeutics
08/16/2012CA2827005A1 Novel 1-(1-oxo-1,2,3,4-tetrahydroisoquinolin-7-yl)urea derivatives as n-formyl peptide receptor like-1 (fprl-1) receptor modulators
08/15/2012EP2487153A1 Substituted cyclopentanes having prostaglandin activity
08/15/2012EP2486009A1 2h-pyrrol-5-amine derivatives as alpha adrenergic receptor modulators
08/15/2012EP1864666B1 Protective agent for retinal neuronal cell containing prostaglandin f2 alpha derivative as active ingredient
08/15/2012EP1791568B1 Therapeutic uses of inhibitors of rtp801
08/15/2012EP1438295B1 Azole derivatives and pharmaceutical compositions containing them
08/15/2012EP1420716B1 An implantable and sealable system for unidirectional delivery of therapeutic agents to targeted tissues
08/15/2012EP1294391B1 Combination of agents for inhibiting transplant rejection
08/15/2012CN1976938B Thienopyrazole derivative having PDE7 inhibitory activity
08/15/2012CN102639527A Novel phenylpyridine derivative and medicinal agent comprising same
1 ... 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 ... 531